Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic
- PMID: 17163248
- DOI: 10.2165/00044011-200626030-00007
Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic
Abstract
Background: Elderly patients often take multiple drugs. It is known that polypharmacy, i.e. use of five or more drugs, may lead to drug interactions and adverse events. However, undertreatment of conditions or illnesses is also a concern in geriatric patients. A centralised review of both diagnoses and medication may play a key role in optimising pharmacotherapy in geriatric patients. The aims of this study were to evaluate the quality and appropriateness of medication after performing a complete geriatric assessment (CGA) and medication review at a diagnostic geriatric day clinic, to investigate reasons for drug changes, and to determine whether medication review leads to a reduction in the number of drugs used.
Methods: A chart review was performed in 702 patients (mean age 82.0 years, range 57.1-104.1 years) who underwent a CGA at a diagnostic geriatric day clinic. Medication at admission, changes in medication and reasons for changes were noted.
Results: Vitamins, for example folic acid and vitamin B(12) (cyanocobalamin), and trimethoprim for urinary tract infections were the most frequently started medications after CGA and medication review. The number of drugs used was reduced in only a minority of patients (11.7%); reasons for discontinuation were a diagnosis that was no longer relevant (38.8%), adverse events (33.2%) and identification of better pharmacotherapeutic options (22.0%). In 69.2% of the cases a new diagnosis was the reason for starting a new medication, followed by osteoporosis prophylaxis (15.0%) and improvement in pharmacotherapy (10.6%). At admission, patients were taking a mean number of 4.6 drugs (range 0-17). A mean of 0.8 drugs (range from reduction of 5 to addition of 7) had been added per patient, resulting in a mean number of 5.4 (range 0-18) prescribed drugs at discharge.
Conclusion: Evaluation of medication in patients after performing CGA at the geriatric day clinic investigated resulted in relevant medication changes. The main reason for prescribing new drugs was a new diagnosis. Absence of a relevant medical indication was the main reason for stopping drugs. CGA and medication review resulted in a mean net addition of 0.8 drugs per patient.
Similar articles
-
Changes in under-treatment after comprehensive geriatric assessment: an observational study.Drugs Aging. 2010 Oct 1;27(10):831-43. doi: 10.2165/11539330-000000000-00000. Drugs Aging. 2010. PMID: 20883063
-
Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.Am J Geriatr Pharmacother. 2009 Apr;7(2):93-104. doi: 10.1016/j.amjopharm.2009.04.006. Am J Geriatr Pharmacother. 2009. PMID: 19447362
-
The potential clinical benefits of medicines optimisation through comprehensive geriatric assessment, carried out by secondary care geriatricians, in a general practice care setting in North Staffordshire, UK: a feasibility study.BMJ Open. 2017 Sep 28;7(9):e015278. doi: 10.1136/bmjopen-2016-015278. BMJ Open. 2017. PMID: 28963282 Free PMC article.
-
Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use?Drugs Aging. 2011 Jul 1;28(7):509-18. doi: 10.2165/11592010-000000000-00000. Drugs Aging. 2011. PMID: 21721596 Review.
-
Do geriatric outpatients adhere to medication changes advised after assessment? An exploratory pilot study.Curr Clin Pharmacol. 2009 May;4(2):154-8. doi: 10.2174/157488409788184990. Curr Clin Pharmacol. 2009. PMID: 19442081 Review.
Cited by
-
Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly.Drugs Aging. 2011 Apr 1;28(4):283-93. doi: 10.2165/11587040-000000000-00000. Drugs Aging. 2011. PMID: 21428463
-
Opti-Med: the effectiveness of optimised clinical medication reviews in older people with 'geriatric giants' in general practice; study protocol of a cluster randomised controlled trial.BMC Geriatr. 2014 Nov 18;14:116. doi: 10.1186/1471-2318-14-116. BMC Geriatr. 2014. PMID: 25407349 Free PMC article. Clinical Trial.
-
Intervention elements to reduce inappropriate prescribing for older adults with multimorbidity receiving outpatient care: a scoping review.BMJ Open. 2020 Aug 20;10(8):e039543. doi: 10.1136/bmjopen-2020-039543. BMJ Open. 2020. PMID: 32819958 Free PMC article.
-
A composite screening tool for medication reviews of outpatients: general issues with specific examples.Drugs Aging. 2007;24(9):733-60. doi: 10.2165/00002512-200724090-00003. Drugs Aging. 2007. PMID: 17727304 Review.
-
Profile of drug utilization in the elderly living in Porto Alegre, Brazil.Pharm Pract (Granada). 2007 Oct;5(4):179-84. doi: 10.4321/s1886-36552007000400007. Pharm Pract (Granada). 2007. PMID: 25170356 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials